GeneChem
33
14M
7
1.22
2
0.27
2
- Areas of investment
Summary
GeneChem is the famous VC, which was founded in 1997. The venture was found in North America in Canada. The main office of represented VC is situated in the Montru00e9al.
The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Cytochroma, LymphoSign, Osprey Pharmaceuticals USA. Among the most successful fund investment fields, there are Pharmaceutical, Medical. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
The fund is generally included in less than 2 deals every year. The important activity for fund was in 2001. Speaking about the real fund results, this VC is 8 percentage points less often commits exit comparing to other organizations. Opposing the other organizations, this GeneChem works on 9 percentage points more the average amount of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2013.
We also calculated 2 valuable employees in our database.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the GeneChem, startups are often financed by Canadian Medical Discoveries Fund, VentureLink LP, The Still River Fund. The meaningful sponsors for the fund in investment in the same round are Canadian Medical Discoveries Fund, Gimv, Yasuda Enterprise Development. In the next rounds fund is usually obtained by Novo Holdings, VenGrowth Asset Management, VentureLink LP.
Investments analytics
Analytics
- Total investments
- 33
- Lead investments
- 2
- Exits
- 2
- Rounds per year
- 1.22
- Follow on index
- 0.27
- Investments by industry
- Biotechnology (5)
- Pharmaceutical (2)
- Medical (2)
- Health Care (2)
- Therapeutics (1) Show 4 more
- Investments by region
-
- United States (6)
- Canada (1)
- Peak activity year
- 1999
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 25
- Avg. company exit year
- 12
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Avalon Pharmaceuticals | 17 Dec 2001 | Biotechnology, Health Care, Clinical Trials | Early Stage Venture | 70M | United States, Maryland, Germantown |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.